Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Hoeprich

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Clinical use of amphotericin B and derivatives: lore, mystique, and factP D Hoeprich
Annual Review of Pharmacology and Toxicology|January 1, 1978
Chemotherapy of systemic fungal diseasesP D Hoeprich
California Medicine|February 1, 1973
Illicit intravenous drug use and bacterial endocarditisP D Hoeprich
California Medicine|February 1, 1970
Etiologic diagnosis of lower respiratory tract infectionsP D Hoeprich
The Journal of Infection|March 1, 1990
Elimination half-life of amphotericin BP D Hoeprich
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
New antifungal drugs in the therapy of systemic mycosesP D Hoeprich
JAMA|November 25, 1974
Miconazole therapy for coccidioidomycosisP D Hoeprich, E Goldstein
The Journal of Infectious Diseases|February 1, 1972
Problems in the diagnosis and treatment of systemic candidiasisE Goldstein, P D Hoeprich
California Medicine|November 1, 1973
Lymphangiography in diagnosis of fever of unknown originE Goldstein, P D Hoeprich
Antimicrobial Agents and Chemotherapy|September 1, 1973
In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus speciesA L Barry, P D Hoeprich
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Clinical use of amphotericin B and derivatives: lore, mystique, and factP D Hoeprich
Annual Review of Pharmacology and Toxicology|January 1, 1978
Chemotherapy of systemic fungal diseasesP D Hoeprich
California Medicine|February 1, 1973
Illicit intravenous drug use and bacterial endocarditisP D Hoeprich
California Medicine|February 1, 1970
Etiologic diagnosis of lower respiratory tract infectionsP D Hoeprich
The Journal of Infection|March 1, 1990
Elimination half-life of amphotericin BP D Hoeprich
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
New antifungal drugs in the therapy of systemic mycosesP D Hoeprich
JAMA|November 25, 1974
Miconazole therapy for coccidioidomycosisP D Hoeprich, E Goldstein
The Journal of Infectious Diseases|February 1, 1972
Problems in the diagnosis and treatment of systemic candidiasisE Goldstein, P D Hoeprich
California Medicine|November 1, 1973
Lymphangiography in diagnosis of fever of unknown originE Goldstein, P D Hoeprich
Antimicrobial Agents and Chemotherapy|September 1, 1973
In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus speciesA L Barry, P D Hoeprich
Pageof 11